![Matt Hall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matt Hall
Investor Relations Contact chez
ANIKA THERAPEUTICS, INC.
Profil
Mr. Matt Hall is a Director-Development & Investor Relations at Anika Therapeutics, Inc. and a Senior Vice President at The Central Indiana Corporate Partnership.
He is on the Board of Directors at Allinaire Therapeutics LLC and Diagnotes, Inc. Mr. Hall was previously employed as a Managing Director by BioCrossroads and a Vice President by NatCity Investments, Inc. He received his undergraduate degree from Indiana University and a graduate degree from Butler University.
Postes actifs de Matt Hall
| Sociétés | Poste | Début |
|---|---|---|
| ANIKA THERAPEUTICS, INC. | Investor Relations Contact | 01/09/2024 |
Diagnotes, Inc.
 Diagnotes, Inc. Packaged SoftwareTechnology Services Provides a communication platform for on-call healthcare services | Directeur/Membre du Conseil | - |
Allinaire Therapeutics LLC
 Allinaire Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for cardiopulmonary diseases | Directeur/Membre du Conseil | 01/01/2016 |
The Central Indiana Corporate Partnership
 The Central Indiana Corporate Partnership Miscellaneous Commercial ServicesCommercial Services Engages in focusing on human capital, entrepreneurship and innovation & business climate | Corporate Officer/Principal | 01/11/2004 |
Anciens postes connus de Matt Hall
| Sociétés | Poste | Fin |
|---|---|---|
BioCrossroads
 BioCrossroads Investment ManagersFinance BioCrossroads seeks investment opportunities in companies located in the United States. The firm targets companies operating in the fields of pharmaceutical, medical device, diagnostics, ag-biotech, health information technology and platforms sectors. It provides financing for seed and early stage capital requirements. | Private Equity Investor | 30/03/2022 |
NatCity Investments, Inc.
 NatCity Investments, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Formation de Matt Hall
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
78
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Anika Therapeutics, Inc.
 Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair | Health Technology |
NatCity Investments, Inc.
NatCity Investments, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Diagnotes, Inc.
Diagnotes, Inc. Packaged SoftwareTechnology Services Provides a communication platform for on-call healthcare services | Technology Services |
Butler University
 Butler University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indiana University
 Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Central Indiana Corporate Partnership
The Central Indiana Corporate Partnership Miscellaneous Commercial ServicesCommercial Services Engages in focusing on human capital, entrepreneurship and innovation & business climate | Commercial Services |
BioCrossroads
BioCrossroads Investment ManagersFinance BioCrossroads seeks investment opportunities in companies located in the United States. The firm targets companies operating in the fields of pharmaceutical, medical device, diagnostics, ag-biotech, health information technology and platforms sectors. It provides financing for seed and early stage capital requirements. | Finance |
Allinaire Therapeutics LLC
Allinaire Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for cardiopulmonary diseases | Health Technology |
